Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma

NCT03302884 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Carcinoma

Interventions

OTHER: biological sampling

Sponsor

Institut Paoli-Calmettes

Collaborators

[object Object]